Fri, Oct 28, 2016
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Vulpes Investment Management announces launch of Vulpes Life-Sciences Fund

Thursday, March 01, 2012
Opalesque Industry Update - Over the past 12 years, the Vulpes partners have acquired significant stakes in a small number of selective, largely UK-based, life-science companies which they believe offer a huge discount to fair value.

These assets will now be offered in a fund structure for co-investment, continuing our plan to move all the partners’ significant assets into fund structures available for external investors.

Summary of Vulpes Life Sciences Fund:

• Small number of companies where IP/technology around diagnostics or drug discovery is very large compared to valuations
• Use of expert advice in proteomics to asses value
• Advise companies in business acumen to increase commercial value

“The UK venture capital market in life sciences in the UK can be very undervalued compared to the world class ideas coming out of UK universities and research institutes which has left the sector somewhat orphaned. We see great potential value in lifescience companies housing world-leading research and development and making significant advances in the treatment of a number of major diseases” said Stephen Diggle, Founder. “The Vulpes Life-Sciences Fund will focus on a select group of companies that possess significantly undervalued intellectual property in both diagnostics and discovery, and will use Vulpes’ experience and expertise to help maximize their commercial value”.

Vulpes Investment Management launched on 1st April 2011 and now has 5 funds open to investors: Long Asian Volatility and Arbitrage Fund, Russian Opportunities Fund and Testudo Fund; the Creo European Investments Fund and now the Vulpes Life Sciences Fund. The Vulpes Agricultural Fund will be added to the platform in the coming months. Corporate website:Source

(press release)


What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. David Einhorn speaks on passive investing, Mylan, his cheapest stock, the Fed[more]

    From Greenlight Capital hedge fund manager David Einhorn (Trades, Portfolio) joined nine other famed investors on Tuesday to talk about stocks at the annual Great Investors’ Best Ideas Investment Symposium in Dallas. Presenters at the annual conference typically pitch one or severa

  2. Investing - Fund set up to buy illiquid hedge fund stakes finds plenty of opportunities, Lansdowne's Roden says likes animal genetics company Genus[more]

    Fund set up to buy illiquid hedge fund stakes finds plenty of opportunities From As ValueWalk reported back in February, earlier this year Andrew Lawrence set out to raise $250 million to $500 million for a fund that will buy stakes in hedge funds that have suspended redem

  3. Other Voices: Don’t mistake style for skill — The impact of style factors on trend follower performance[more]

    By John Dolfin, CFA Chief Investment Officer and Christopher Maxey, CAIA, Senior Portfolio Manager of Steben & Company: Managed futures have become an alternative asset class that is widely used by investors seeking overall portfolio diversification and absolute returns independent of the

  4. Opalesque Roundtable: Style drift, poor communications and credibility fatigue are biggest red flags for hedge funds investors[more]

    Komfie Manalo, Opalesque Asia: Style drift, poor communications and credibility fatigue are the biggest red flags for hedge funds investors, said participants of the latest 2016 Opalesque Investor Roundtable, sponso

  5. Barclay CTA Index down 0.40% in September (+0.10% YTD)[more]

    Managed futures traders lost 0.40% in September according to the Barclay CTA Index compiled by BarclayHedge. The Index is up 0.10% year to date. “The US Fed, in spite of its hawkish tone, opted to hold rates steady which roiled financial markets,” says Sol Waksman, founder and president of BarclayHe